Harel Insurance Investments & Financial Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $575K | Buy |
7,353
+1,859
| +34% | +$145K | 0.01% | 214 |
|
|
2025
Q1 | $398K | Buy |
5,494
+595
| +12% | +$43.1K | 0.01% | 227 |
|
|
2024
Q4 | $363K | Sell |
4,899
-917
| -16% | -$67.9K | 0.01% | 172 |
|
|
2024
Q3 | $384K | Buy |
5,816
+2,032
| +54% | +$134K | 0.01% | 180 |
|
|
2024
Q2 | $350K | Buy |
3,784
+792
| +26% | +$73.3K | 0.01% | 199 |
|
|
2024
Q1 | $286K | Sell |
2,992
-32
| -1% | -$3.06K | 0.01% | 216 |
|
|
2023
Q4 | $231K | Sell |
3,024
-538
| -15% | -$41.1K | ﹤0.01% | 271 |
|
|
2023
Q3 | $247K | Buy |
3,562
+1,510
| +74% | +$105K | ﹤0.01% | 273 |
|
|
2023
Q2 | $194K | Buy |
2,052
+1,622
| +377% | +$153K | ﹤0.01% | 315 |
|
|
2023
Q1 | $35K | Hold |
430
| – | – | ﹤0.01% | 534 |
|
|
2022
Q4 | $32K | Hold |
430
| – | – | ﹤0.01% | 538 |
|
|
2022
Q3 | $36K | Hold |
430
| – | – | ﹤0.01% | 541 |
|
|
2022
Q2 | $41K | Hold |
430
| – | – | ﹤0.01% | 536 |
|
|
2022
Q1 | $51K | Sell |
430
-14,620
| -97% | -$1.73M | ﹤0.01% | 510 |
|
|
2021
Q4 | $1.96M | Buy |
15,050
+14,500
| +2,636% | +$1.89M | 0.04% | 122 |
|
|
2021
Q3 | $62K | Sell |
550
-1,388
| -72% | -$156K | ﹤0.01% | 511 |
|
|
2021
Q2 | $654K | Sell |
1,938
-682
| -26% | -$230K | 0.01% | 400 |
|
|
2021
Q1 | $732K | Buy |
2,620
+222
| +9% | +$62K | 0.01% | 430 |
|
|
2020
Q4 | $704K | Buy |
2,398
+550
| +30% | +$161K | 0.02% | 317 |
|
|
2020
Q3 | $148K | Buy |
1,848
+1,400
| +313% | +$112K | 0.01% | 344 |
|
|
2020
Q2 | $31K | Buy |
+448
| New | +$31K | ﹤0.01% | 430 |
|